Roberta Dal Magro

ORCID: 0000-0001-9602-0935
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoparticle-Based Drug Delivery
  • Lipid Membrane Structure and Behavior
  • Alzheimer's disease research and treatments
  • Advanced Drug Delivery Systems
  • Gold and Silver Nanoparticles Synthesis and Applications
  • Nanoplatforms for cancer theranostics
  • RNA Interference and Gene Delivery
  • Drug Transport and Resistance Mechanisms
  • Nanocluster Synthesis and Applications
  • Supramolecular Self-Assembly in Materials
  • Air Quality and Health Impacts
  • Barrier Structure and Function Studies
  • Cholesterol and Lipid Metabolism
  • Inhalation and Respiratory Drug Delivery
  • Molecular Communication and Nanonetworks
  • Advancements in Transdermal Drug Delivery
  • Advanced Polymer Synthesis and Characterization
  • Cancer Research and Treatment
  • Climate Change and Health Impacts
  • Ion Transport and Channel Regulation
  • Cell death mechanisms and regulation
  • Microwave-Assisted Synthesis and Applications
  • Advanced Electron Microscopy Techniques and Applications
  • Advanced biosensing and bioanalysis techniques
  • Computational Drug Discovery Methods

Instituto de Ciencia de Materiales de Madrid
2024

University of Milano-Bicocca
2016-2021

Engineered nanoparticles offer the chance to improve drug transport and delivery through biological barriers, exploiting possibility leave blood circulation traverse endothelial vascular bed, blood–brain barrier (BBB) included, reach their target. It is known that gather molecules on surface upon contact with fluids, forming "protein corona", which can affect fate therapeutic/diagnostic performance, yet no information corona's evolution across has been gathered so far. Using a cellular model...

10.1021/acsnano.8b03500 article EN publisher-specific-oa ACS Nano 2018-06-28

Much evidence suggests a protective role of high-density lipoprotein (HDL) and its major apolipoprotein apoA-I, in Alzheimer's disease (AD). The biogenesis nascent HDL derived from first lipidation which is synthesized by the liver intestine but not brain, process mediated ABCA1. maturation mature spherical due to subsequent step, LCAT-mediated cholesterol esterification, change apoA-I conformation. Therefore, different subclasses apoA-I-HDL simultaneously exist blood circulation. Here, we...

10.3389/fnins.2019.00419 article EN cc-by Frontiers in Neuroscience 2019-05-16

Nanoparticles may provide a viable way for neuroprotective drugs to cross the blood–brain barrier (BBB), which limits passage of most from peripheral circulation brain. Heterotelechelic polymer prodrugs comprising model drug (adenosine) and maleimide functionality were synthesized by "drug-initiated" approach subsequent nitroxide exchange reaction. obtained nanoprecipitation exhibited high colloidal stability with diameters in 162–185 nm range narrow size distributions. then covalently...

10.1016/j.ejpb.2019.06.004 article EN cc-by-nc-nd European Journal of Pharmaceutics and Biopharmaceutics 2019-06-07

Despite advances in cancer therapies, nanomedicine approaches including the treatment of glioblastoma (GBM), most common, aggressive brain tumor, remains inefficient. These failures are likely attributable to complex and not yet completely known biology this which is responsible for its strong invasiveness, high degree metastasis, proliferation potential, resistance radiation chemotherapy. The intimate connection through cells communicate between them plays an important role these biological...

10.3389/fbioe.2019.00403 article EN cc-by Frontiers in Bioengineering and Biotechnology 2019-12-11

H-ferritin nanoconjugates of CTX and TZ are developed as carriers across the BBB to allow immunotherapy primary glioblastoma HER2+ breast cancer brain metastases. The reliability strategy is demonstrated using a transwell barrier model.

10.1039/d0bm01726d article EN Biomaterials Science 2021-01-01

Abstract We designed liposomes dually functionalized with ApoE-derived peptide (mApoE) and chlorotoxin (ClTx) to improve their blood–brain barrier (BBB) crossing. Our results demonstrated the synergistic activity of ClTx-mApoE in boosting doxorubicin-loaded across BBB, keeping anti-tumour drug loaded: mApoE acts promoting cellular uptake, while ClTx promotes exocytosis liposomes.

10.1186/s12951-019-0546-3 article EN cc-by Journal of Nanobiotechnology 2019-11-11

Purpose: Nanotechnologies turned out to be promising in the development of diagnostic and therapeutic approaches toward neurodegenerative disorders. However, only a very scant number nanodevices until now proved effective on preclinical animal models. Although specific tests vivo are available assess potential toxicity these cognitive functions, those evaluate their biosafety vitro neurons still improved. Materials methods: We utilized patch-clamp technique primary cultures cortical neural...

10.2147/ijn.s161563 article EN cc-by International Journal of Nanomedicine 2018-07-01

The cerebral synthesis of cholesterol is mainly handled by astrocytes, which are also responsible for apoproteins’ and lipoproteins’ assembly required the transport in brain parenchyma. In Alzheimer disease (AD), these processes impaired, likely because astrogliosis, a process characterized morphological functional changes astrocytes. Several ATP-binding cassette transporters expressed cells involved formation nascent discoidal lipoproteins, but effect beta-amyloid (Aβ) assemblies on this...

10.3390/ijms23010102 article EN International Journal of Molecular Sciences 2021-12-22

Abstract In the pursuit of enhancing cancer treatment efficacy while minimizing side effects, near‐infrared (NIR) photothermal therapy (PTT) has emerged as a promising approach. By using photothermally active nanomaterials, PTT enables localized hyperthermia, effectively eliminating cells with minimal invasiveness and toxicity. Among these gold nanostars (AuNS) stand out due to their tunable plasmon resonance efficient light absorption. This study addresses challenge measuring nanoscale...

10.1002/adhm.202403799 article EN cc-by-nc-nd Advanced Healthcare Materials 2024-12-11

Aim: To investigate if and how the ability of liposomes, previously designed for Alzheimer's therapy, to reach brain changes in aging/pathological conditions with respect healthy state. Methods: Biodistribution pharmacokinetics liposomes young or aged mice an mouse model were measured by radiochemical techniques. The expression receptors structural proteins was evaluated Western blot. Results: At equal blood levels, amount integrity dramatically lower mice, animals. These differences are...

10.2217/nnm-2017-0317 article EN Nanomedicine 2018-01-29

The deposition of amyloid-β (Aβ) plaques in the brain is a significant pathological signature Alzheimer’s disease, correlating with synaptic dysfunction and neurodegeneration. Several compounds, peptides, or drugs have been designed to redirect stop Aβ aggregation. Among them, trideca-peptide CWG-LRKLRKRLLR (mApoE), which derived from receptor binding sequence apolipoprotein E, effectively able inhibit aggregation promote fibril disaggregation. Taking advantage Atomic Force Microscopy (AFM)...

10.3390/ijms21031066 article EN International Journal of Molecular Sciences 2020-02-05

Vascular oxidative stress is considered a worsening factor in the progression of Alzheimer’s disease (AD). Increased reactive oxygen species (ROS) levels promote accumulation amyloid-β peptide (Aβ), one main hallmarks AD. In turn, Aβ potent inducer stress. early stages AD, concomitant action and on brain capillary endothelial cells was observed to compromise blood–brain barrier functionality. this context, antioxidant compounds might provide therapeutic benefits. To aim, we investigated...

10.3390/antiox10020266 article EN cc-by Antioxidants 2021-02-09

The cell microenvironment plays a pivotal role in mediating adhesion, survival, and proliferation physiological pathological states. relevance of extracellular matrix (ECM) proteins fate control is an important issue to take into consideration for both tissue engineering biology studies. glycosylation ECM remains, however, largely unexplored. In order investigate the physio-pathological effects differential glycosylation, design affordable chemoselective methods components desirable. We will...

10.3390/ijms20071747 article EN International Journal of Molecular Sciences 2019-04-09
Coming Soon ...